Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications

Oral Diseases - Tập 15 Số 6 - Trang 388-399 - 2009
C Scully1, José Vicente Bagán Sebastián2
1Univ College London, London, UK
2Valencia University and Hospital General Universitario de Valencia, Valencia, Spain

Tóm tắt

MEDLINE contains well over 14 000 papers revealed by a search using keywords ‘oral squamous cell cancer’ or ‘oral squamous cell carcinoma’, over 27 000 using ‘oral carcinoma’ and over 48 000 using the keywords ‘oral cancer’. It is difficult to see how clinicians could keep abreast of such a subject. This paper attempts to help by providing an overview of the aetiopathogenesis of oral squamous cell carcinoma (OSCC), discussing changes in epidemiology and increasing awareness of the wide range of risk factors, emphasising the genetic background to cancer susceptibility and the genetic changes associated with progression to OSCC and highlighting clinical implications.

Từ khóa


Tài liệu tham khảo

10.1016/S1079-2104(05)80201-X

10.1158/1055-9965.EPI-08-0558

Angiero F, 2008, Expression of p16, p53 and Ki‐67 proteins in the progression of epithelial dysplasia of the oral cavity, Anticancer Res, 28, 2535

10.1093/carcin/bgl206

10.1016/j.oraloncology.2008.12.012

10.1002/cncr.22386

10.1177/014556139707601109

10.1111/j.1600-0714.2008.00715.x

10.1016/j.oraloncology.2006.11.006

10.1007/s00432-007-0254-5

10.1158/1055-9965.EPI-08-0462

10.1016/j.canlet.2008.07.026

10.1016/S1470-2045(08)70173-6

Boldrup L, 2005, Expression of p63, COX‐2, EGFR and beta‐catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non‐neoplastic tissue and no obvious changes in smokers, Int J Oncol, 27, 1661

10.1002/1097-0215(20000901)87:5<734::AID-IJC17>3.0.CO;2-E

10.1016/S0002-9610(05)80092-3

Braakhuis BJ, 2003, A genetic explanation of Slaughter’s concept of field cancerization: evidence and clinical implications, Cancer Res, 63, 1727

10.1111/j.1600-0714.2004.00225.x

10.1093/annonc/mdi713

10.1016/j.semcancer.2004.08.004

10.1016/S0959-8049(01)00350-1

10.1056/NEJM199502163320704

10.1097/01.cco.0000219250.15041.f8

10.1016/j.otc.2005.11.010

10.3109/10408449609017926

10.1002/hed.20867

Califano J, 2000, Genetic progression and clonal relationship of recurrent premalignant head and neck lesions, Clin Cancer Res, 6, 347

10.1038/35025220

Carpenter JM, 2005, Oral carcinoma associated with betel nut chewing in the Pacific: an impending crisis?, Pac Health Dialog, 12, 158

10.1111/j.1349-7006.2008.00863.x

10.1016/j.oraloncology.2008.11.002

10.1016/j.oraloncology.2007.02.008

10.1177/030089168607200312

10.1016/j.oraloncology.2007.07.006

10.1016/j.oraloncology.2007.11.007

10.1016/S1470-2045(04)01633-X

10.1002/1097-0215(20000520)89:3<286::AID-IJC12>3.0.CO;2-U

10.1002/(SICI)1096-9896(199804)184:4<360::AID-PATH1263>3.0.CO;2-H

10.1056/NEJMoa065497

10.1002/cncr.23016

10.1016/j.oraloncology.2005.10.008

10.1002/ijc.21345

10.1016/j.oraloncology.2005.07.010

Drummond SN, 2002, TP53 codon 72 polymorphism in oral squamous cell carcinoma, Anticancer Res, 22, 3379

Duarte EC, 2008, Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression, Anticancer Res, 28, 1101

Dye BA, 2007, Using NHANES oral health examination protocols as part of an esophageal cancer screening study conducted in a high‐risk region of China, BMC Oral Health, 17, 7

10.1016/j.tripleo.2007.01.010

10.1016/j.oraloncology.2007.10.011

10.1111/j.1600-0714.2004.0037n.x

10.1016/j.oraloncology.2004.12.007

10.1067/mhn.2001.114674

10.1158/1055-9965.EPI-04-0546

Friedrich RE, 1997, P53 auto‐antibodies in the sera of patients with oral squamous cell carcinoma, Anticancer Res, 17, 3183

10.1093/ajcn/83.4.835

10.1007/s00394-008-0722-y

Giebułtowicz J, 2008, Fluorimetric detection of aldehyde dehydrogenase activity in human tissues in diagnostic of cancers of oral cavity, Acta Pol Pharm, 65, 81

Glazer CA, 2008, Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice, Oral Oncol

Gottschlich S, 1999, A new prognostic indicator for head and neck cancer – p53 serum antibodies?, Anticancer Res, 19, 2703

10.1016/j.oraloncology.2006.02.004

10.1093/ajcn/85.5.1229

10.1093/aje/kwm193

Guo Z, 2001, Allelic losses in OraTest‐directed biopsies of patients with prior upper aerodigestive tract malignancy, Clin Cancer Res, 7, 1963

10.1016/j.oraloncology.2007.06.003

Ha PK, 2008, Molecular techniques and genetic alterations in head and neck cancer, Oral Oncol

10.1056/NEJMra0707975

10.1016/j.oraloncology.2007.09.004

10.1054/bjoc.1999.1130

10.1016/j.alcohol.2005.04.008

10.1038/ng.151

10.1158/1055-9965.EPI-08-0347

10.1016/j.oraloncology.2007.02.001

Hein DW, 2000, Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms, Cancer Epidemiol Biomarkers Prev, 9, 29

Hirota SK, 2008, Risk factors for oral squamous cell carcinoma in young and older Brazilian patients: a comparative analysis, Med Oral Patol Oral Cir Bucal, 13, E227

10.1080/009841097160393

Holmes L Jr, 2008, Is dental care utilization associated with oral cavity cancer in a large sample of community‐based United States residents?, Community Dent Oral Epidemiol

10.1111/j.1600-0714.2007.00513.x

Van Houten VM, 2000, Molecular assays for the diagnosis of minimal residual head‐and‐neck cancer: methods, reliability, pitfalls, and solutions, Clin Cancer Res, 6, 3803

10.1007/978-3-642-57151-0_8

10.1177/154405910608501212

10.1196/annals.1384.015

10.1158/1078-0432.CCR-07-5037

IARC, 2004, GLOBOCAN 2002, Cancer Incidence, Mortality and Prevalence Worldwide (2002 estimates)

10.1093/jnci/95.3.198

10.1016/j.oraloncology.2004.01.005

10.1002/j.0022-0337.2001.65.4.tb03403.x

Kannan S, 1997, Telomerase activity in premalignant and malignant lesions of human oral mucosa, Cancer Epidemiol Biomarkers Prev, 6, 413

10.1111/j.1600-0714.1995.tb01166.x

Kim HR, 2001, Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ, Clin Cancer Res, 7, 3079

10.1016/j.oraloncology.2005.06.013

10.1016/j.oraloncology.2006.02.005

10.1016/j.oraloncology.2008.08.012

10.1016/j.oraloncology.2003.09.013

Lee JJ, 2000, Predicting cancer development in oral leukoplakia: ten years of translational research, Clin Cancer Res, 6, 1702

10.1016/j.oraloncology.2007.10.006

10.1016/j.oraloncology.2007.06.011

10.1016/0360-3016(89)90126-0

10.1016/S1368-8375(00)00135-4

Losi‐Guembarovski R, 2008, Lack of association among polymorphic xenobiotic‐metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population, Anticancer Res, 28, 1023

Lucenteforte E, 2008, Dietary factors and oral and pharyngeal cancer risk, Oral Oncol

10.1111/j.1365-2559.2004.01892.x

Maass JD, 1997, Head and neck cancer and p53‐immunogenicity, Anticancer Res, 17, 2873

10.1002/ijc.22547

10.1016/j.oraloncology.2005.11.003

10.1093/aje/kwj233

10.1002/ijc.22448

10.1016/j.oraloncology.2005.10.003

10.1021/tx060113h

10.1111/j.1834-7819.2008.00070.x

10.1002/(SICI)1097-0215(20000401)86:1<128::AID-IJC20>3.0.CO;2-M

10.1007/s10552-008-9163-4

10.1111/j.1601-0825.2006.01349.x

Molinolo AA, 2008, Dysregulated molecular networks in head and neck carcinogenesis, Oral Oncol

10.1111/j.1601-0825.1999.tb00300.x

10.1111/j.1601-0825.2000.tb00105.x

10.1111/j.1601-0825.2000.tb00104.x

Mutirangura A, 1996, Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma, Cancer Res, 56, 3530

10.1002/1097-0215(20001101)88:3<342::AID-IJC4>3.0.CO;2-I

10.1016/j.oraloncology.2007.06.002

10.1016/j.archoralbio.2006.08.014

Park S, 2008, Aetiology of cancer in Asia, Asian Pac J Cancer Prev, 9, 371

10.1177/10454411010120010401

10.1097/COC.0b013e31816a61da

10.1093/ajcn/83.5.1126

10.1093/annonc/mdg448

10.1097/CEJ.0b013e3282f75e91

Petti S, 2008, Lifestyle risk factors for oral cancer, Oral Oncol

10.1016/j.oraloncology.2005.12.027

10.1158/1055-9965.EPI-05-0983

10.1002/cncr.24157

10.4161/cbt.5.9.3065

10.1177/154411130301400105

10.1111/j.1600-0714.2008.00669.x

10.1080/01635580801956477

10.1016/j.oraloncology.2003.08.014

10.1038/ng1502

10.1158/1055-9965.EPI-07-0168

10.1016/j.yexmp.2006.05.001

Sanz‐Ortega J, 2007, 17p13 (p53 locus), 5q21 (APC locus) and 9p21 (p16 locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non‐small‐cell lung cancer, Histol Histopathol, 22, 541

10.1007/s10552-008-9183-0

10.1080/09603120701254813

10.1159/000076911

Schwartz SM, 2001, Oral squamous cell cancer risk in relation to alcohol consumption and alcohol dehydrogenase‐3 genotypes, Cancer Epidemiol Biomarkers Prev, 10, 1137

10.1016/0964-1955(94)00049-A

10.1016/S1368-8375(01)00098-7

10.1038/sj.bdj.4812612

10.1016/S1470-2045(00)00008-5

10.1016/B978-012373960-5.00256-2

10.1016/S1368-8375(00)00007-5

10.1016/S1368-8375(00)00021-X

10.1016/S1368-8375(00)00023-3

10.1034/j.1600-0714.2003.00108.x

10.1007/978-1-60327-492-0_9

10.1038/nrc2191

10.1016/j.oraloncology.2008.02.012

10.1038/sj.bjc.6602972

10.1016/j.bjoms.2007.04.015

Shillitoe EJ, 2008, The role of viruses in squamous cell carcinoma of the oropharyngeal mucosa, Oral Oncol

10.1007/s00432-007-0207-z

10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q

10.1111/j.1601-0825.2007.01437.x

10.1186/1471-2164-9-259

10.1002/(SICI)1097-0215(19990105)80:1<1::AID-IJC1>3.0.CO;2-U

10.1158/1078-0432.CCR-08-0930

10.1111/j.1349-7006.2006.00232.x

10.1158/1078-0432.CCR-03-0632

10.1111/j.1600-0714.2008.00644.x

10.1002/(SICI)1097-0215(19981029)78:3<390::AID-IJC23>3.0.CO;2-9

10.1001/archotol.133.5.450

10.1002/ijc.22304

10.1002/ijc.23739

10.1054/ijom.2002.0220

10.1016/j.oraloncology.2005.12.019

10.1111/j.1600-0714.1998.tb01973.x

10.1016/S1368-8375(98)00127-4

Trullenque‐Eriksson A, 2009, Analysis of new diagnostic methods in suspicious lesions of the oral mucosa, Med Oral Patol Oral Cir Bucal

10.1016/j.tox.2008.05.007

Vallecillo Capilla M, 2007, Factors related to survival from oral cancer in an Andalusian population sample (Spain), Med Oral Patol Oral Cir Bucal, 12, E518

10.1097/GIM.0b013e3181770196

Viet CT, 2007, DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer, J Calif Dent Assoc, 35, 844, 10.1080/19424396.2007.12221293

10.1016/S1079-2104(05)80199-4

Van Der Waal I, 2008, Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management, Oral Oncol

Wang J, 2006, Salivary oral cancer transcriptome biomarkers (SOCTB) for clinical detection

10.1158/1078-0432.CCR-06-1911

10.1002/(SICI)1096-9896(200003)190:4<407::AID-PATH546>3.0.CO;2-D

Warnakulasuriya S, 2008, Global epidemiology of oral and oropharyngeal cancer, Oral Oncol

10.1111/j.1600-0714.2007.00496.x

Winn DM, 1995, Diet and nutrition in the etiology of oral cancer, Am J Clin Nutr, 61, 437S, 10.1093/ajcn/61.2.437S

Wong DT, 2006, Salivary diagnostics for oral cancer, J Calif Dent Assoc, 34, 303, 10.1080/19424396.2006.12222198

10.1074/mcp.M700146-MCP200

10.1016/j.oraloncology.2003.08.017

10.1002/cncr.23854

10.1093/jjco/hyg026

10.1002/ijc.22792

10.1111/j.1530-0277.2008.00739.x

10.1016/S1368-8375(00)00133-0

10.1002/ijc.1642

10.1158/0008-5472.CAN-04-3153

10.1007/BF00117475

10.1016/j.archoralbio.2007.05.005

10.1080/07357900802146170

10.1196/annals.1384.002